CrystalGenomics Inc
KOSDAQ:083790
CrystalGenomics Inc
Other
CrystalGenomics Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
CrystalGenomics Inc
KOSDAQ:083790
|
Other
-₩323.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other
₩628.1B
|
CAGR 3-Years
88%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Other
-₩60.8m
|
CAGR 3-Years
28%
|
CAGR 5-Years
-75%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other
-₩23m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other
-₩55.4m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
CrystalGenomics Inc
Glance View
CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2006-01-06. The firm operates its business through four segments. The Drug Substance Manufacturing segment manufactures and sells drug substances such as anti-inflammatory analgesics, antispasmodics, and asthma treatments. The Finished Drug Manufacturing segment produces and supplies finished drugs such as cephalosporin antibiotics. The Pharmaceutical Research and Development segment is engaged in the provision of clinical trial analysis and technical services, and sales of new drugs. The company also engages in real estate rental business. The Other segment is engaged in the manufacture and sale of hot pats and other household goods.
See Also
What is CrystalGenomics Inc's Other?
Other
-323.2m
KRW
Based on the financial report for Sep 30, 2025, CrystalGenomics Inc's Other amounts to -323.2m KRW.
What is CrystalGenomics Inc's Other growth rate?
Other CAGR 5Y
44%
